Short-term renal and metabolic effects of low dose vildagliptin treatment added-on insulin therapy in non-proteinuric patients with type 2 diabetes: open-label randomized prospective study

ABSTRACT Objective The aim of this randomized comparative study was to assess renal and metabolic effects of vildagliptin in insulin-treated type 2 diabetes (T2DM) patients without overt chronic kidney disease. Subjects and methods We randomized 47 insulin-treated non-proteinuric patients with sat...

Полное описание

Библиографические подробности

Главные авторы:	Valentina K. Bayrasheva, Ivan Y. Pchelin, Vladimir A. Dobronravov, Alina Yu. Babenko, Svetlana G. Chefu, Ivan S. Shatalov, Volha N. Vasilkova, Natalia V. Hudiakova, Alexandra N. Ivanova, Pavel A. Andoskin, Elena N. Grineva
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Sociedade Brasileira de Endocrinologia e Metabologia 2020-04-01
Серии:	Archives of Endocrinology and Metabolism
Предметы:	Vildagliptin type 2 diabetes renal function NGAL cystatin C type IV collagen
Online-ссылка:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972020000400418&tlng=en
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!